0001144204-14-008359.txt : 20140213 0001144204-14-008359.hdr.sgml : 20140213 20140213120353 ACCESSION NUMBER: 0001144204-14-008359 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140213 DATE AS OF CHANGE: 20140213 GROUP MEMBERS: GOOGLE VENTURES 2011 GP, L.L.C. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Foundation Medicine, Inc. CENTRAL INDEX KEY: 0001488613 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271316416 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87922 FILM NUMBER: 14604172 BUSINESS ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-418-2200 MAIL ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Google Ventures 2011, L.P. CENTRAL INDEX KEY: 0001586699 IRS NUMBER: 274220071 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1600 AMPHITHEATRE PARKWAY CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: (650) 214-2003 MAIL ADDRESS: STREET 1: 1600 AMPHITHEATRE PARKWAY CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 SC 13G 1 v367542_13g.htm SC 13G

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Schedule 13G

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND
AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)

(Amendment No. __)*

 

Foundation Medicine, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

350465100

 


(CUSIP Number)

 

December 31, 2013

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ¨ Rule 13d-1(b)
  ¨ Rule 13d-1(c)
  x Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

(Continued on following pages)

 

Page 1 of 12 Pages
Exhibit Index on Page 7

 

 
 

 

CUSIP NO. 350465100 13 G Page 2 of 9 Pages

  

 

1 NAME OF REPORTING PERSONS

      Google Ventures 2011, L.P. (“GV 2011”)
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      (Inclusion of number is not required)
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_] (b) [X]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware

NUMBER OF

SHARES

BENEFICIALLY 

OWNED BY EACH

REPORTING

PERSON

WITH

 

5 SOLE VOTING POWER
2,444,653 shares, except that Google Ventures 2011 GP, L.L.C. (“GP 2011”), the general partner of GV 2011, may be deemed to have sole power to vote these shares.  
6 SHARED VOTING POWER
See response to row 5.
7 SOLE DISPOSITIVE POWER
2,444,653 shares, except that GP 2011 may be deemed to have sole power to dispose of these shares.
8 SHARED DISPOSITIVE POWER
See response to row 7.
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON 2,444,653
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES [_]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.69%
12 TYPE OF REPORTING PERSON
PN
       

 

 

 
 

 

 

CUSIP NO. 350465100 13 G Page 3 of 9 Pages

 

1 NAME OF REPORTING PERSONS
     Google Ventures 2011 GP, L.L.C.

SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     (Inclusion of number is not required)
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_] (b) [X]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON

WITH

 

5 SOLE VOTING POWER
2,444,653 shares directly held by GV 2011.  GP 2011, the general partner of GV 2011, may be deemed to have the sole power to vote these shares.
6 SHARED VOTING POWER
See response to row 5.
7 SOLE DISPOSITIVE POWER.  
2,444,653 shares directly held by GV 2011.  GP 2011, the general partner of GV 2011, may be deemed to have the sole power to dispose of these shares.
8 SHARED DISPOSITIVE POWER
See response to row 7.
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON 2,444,653
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES [_]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.69%
12 TYPE OF REPORTING PERSON
OO
       

 

 
 

 

 

CUSIP NO. 350465100 13 G Page 4 of 9 Pages

 

ITEM 1(A). NAME OF ISSUER:
  Foundation Medicine, Inc.
   
ITEM 1(B). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
  150 Second Street
  Cambridge, MA 02141
   
ITEM 2(A). NAME OF PERSONS FILING:
  This statement is filed by Google Ventures 2011, L.P. (“GV 2011”) and Google Ventures 2011 GP, L.L.C. (“GP 2011”), the general partner of GV 2011.  The foregoing entities are collectively referred to as the “Reporting Persons.”  
   
  GP 2011 is the general partner of GV 2011 and may be deemed to have sole power to vote and sole power to dispose of shares of the issuer directly owned by GV 2011.   Voting and dispositive power with respect to the shares held by GV 2011 reside with the Google Ventures Investment Committee, no member of which has veto power.
   
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:
  The address of the principal business office for each of the Reporting Persons is:
   
  Google Ventures
  1600 Amphitheatre Parkway
  Mountain View, CA  94043
   
ITEM 2(C) CITIZENSHIP:
  GV 2011 is a Delaware limited partnership and GP 2011 is a Delaware limited liability company.
   
ITEM 2(D)/E TITLE OF CLASS OF SECURITIES AND CUSIP NUMBER:
  Common Stock
  CUSIP # 350465100
   
ITEM 3. Not Applicable.
   
ITEM 4. OWNERSHIP:
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.  

 

 
 

 

 

CUSIP NO. 350465100 13 G Page 5 of 9 Pages

 

(a) Amount beneficially owned:

See Row 9 of cover page for each Reporting Person.

 

(b) Percent of Class:

See Row 11 of cover page for each Reporting Person.

 

(c) Number of shares as to which such person has:

 

(i)Sole power to vote or to direct the vote:

 

See Row 5 of cover page for each Reporting Person.

 

(ii)Shared power to vote or to direct the vote:

 

See Row 6 of cover page for each Reporting Person.

 

(iii)Sole power to dispose or to direct the disposition of:

 

See Row 7 of cover page for each Reporting Person.

 

(iv)Shared power to dispose or to direct the disposition of:

 

See Row 8 of cover page for each Reporting Person.

 

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
  Not applicable.
   
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
  Under certain circumstances set forth in the limited partnership agreement of GV 2011 and the limited liability company agreement of GP 2011, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a general partner, limited partner, or member.
   
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
  Not applicable.
   
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
  Not applicable.
   
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
  Not applicable.

 

 
 

 

 

CUSIP NO. 350465100 13 G Page 6 of 9 Pages

 

ITEM 10. CERTIFICATION:
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 
 

 

 

CUSIP NO. 350465100 13 G Page 7 of 9 Pages

 

SIGNATURES

 

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Dated: February 12, 2014

 

Google Ventures 2011, L.P.

By Google Ventures 2011 GP, L.L.C, its General Partner

By Google Inc., its Managing Member

 

 

By: /s/ David C. Drummond

Name: David C. Drummond

Title: Senior V.P. and Chief Legal Officer



Google Ventures 2011 GP, L.L.C

By Google Inc., its Managing Member

 

 

By: /s/ David C. Drummond

Name: David C. Drummond

Title: Senior V.P. and Chief Legal Officer

 

 

 
 

 

 

CUSIP NO. 350465100 13 G Page 8 of 9 Pages

 

EXHIBIT INDEX

 

  Found on Sequentially
Exhibit Numbered Page
Exhibit A:  Agreement of Joint Filing 8
   

 

 
 

 

 

CUSIP NO. 350465100 13 G Page 9 of 9 Pages

 

exhibit A

 

Agreement of Joint Filing

 

The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock of Foundation Medicine, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.

 

Date: February 12, 2014

 

 

 

Google Ventures 2011, L.P.

By Google Ventures 2011 GP, L.L.C, its General Partner

By Google Inc., its Managing Member

 

 

By: /s/ David C. Drummond

Name: David C. Drummond

Title: Senior V.P. and Chief Legal Officer



Google Ventures 2011 GP, L.L.C

By Google Inc., its Managing Member

 

 

By: /s/ David C. Drummond

Name: David C. Drummond

Title: Senior V.P. and Chief Legal Officer